NIH-funded research R15 grant

Understanding how reactive oxygen species affect wound healing and tissue repair

Official title: ROS Signaling in Wound Healing vs Tissue Repair

Funded at Western Michigan University · NIH-10654242 · Data updated 2026-11-12

This study is looking at how certain molecules in the body, called reactive oxygen species, affect healing wounds, especially for people with diabetes or obesity, to find better ways to help them heal and reduce scarring.

More Wound Healing research and trials

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionWestern Michigan University
NIH-funded
Lab location1 site (Kalamazoo, United States)
Project startMay 1, 2023
Project endApril 30, 2026
Funding year2023
Award (this year)$444,329
NIH project number1R15GM150073-01
Project IDNIH-10654242 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals with diabetes, obesity, or other conditions that impair wound healing.

Less likely to help

Patients with acute injuries that heal normally without complications may not benefit from this research.

What this research studies

This research investigates the role of reactive oxygen species (ROS) in wound healing and tissue repair, particularly in patients with conditions like diabetes and obesity that complicate healing. The study aims to identify specific ROS signaling pathways that contribute to either effective healing or scar formation. By using model organisms, the researchers will explore how manipulating these pathways could improve healing outcomes. Patients may benefit from insights that could lead to new treatments for chronic wounds and fibrosis-related diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for chronic wounds and enhanced tissue regeneration.

How similar studies have gone: Other research has shown promise in understanding ROS roles in healing, but this approach aims to clarify conflicting evidence and explore novel pathways.

Where this research is happening

  • Western Michigan University
    Kalamazoo, United States
    Active

Researchers

  • Principal investigator: Beane, Wendy Scott — Western Michigan University
  • Study coordinator: Beane, Wendy Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.